FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy

  1. Xiao, Y.
  2. Yin, C.
  3. Wang, Y.
  4. Lv, H.
  5. Wang, W.
  6. Huang, Y.
  7. Perez-Losada, J.
  8. Snijders, A.M.
  9. Mao, J.-H.
  10. Zhang, P.
Journal:
Molecular Oncology

ISSN: 1878-0261 1574-7891

Year of publication: 2018

Volume: 12

Issue: 6

Pages: 883-895

Type: Article

DOI: 10.1002/1878-0261.12200 GOOGLE SCHOLAR lock_openOpen access editor